Results 61 to 70 of about 4,744 (174)

Reply to “Sural/Radial Amplitude Ratio in Non‐Length‐Dependent Neuropathy (NLDN): A Call for More Standardized Methodology and Further Evaluation of Distal NLDN”

Muscle &Nerve, Volume 74, Issue 3, Page 761-762, September 2026.
Antoine Pegat, Guillaume Fargeot, Françoise Bouhour   +2 more
wiley   +1 more source

Dynametric assessment in CIDP [PDF]

Muscle & Nerve, 2009
In this issue, Harbo and colleagues,3 use a number of common measures, including manual muscle testing, as done in the Neuropathy Impairment Score (NIS), attributes of nerve conduction (NCs), quantitative sensation testing (QST) using CASE IV, functional activity scales (9-hole peg and 40-meter walk), and short SF-36 quality of life scales for ...
openaire   +1 more source

Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study

Frontiers in Neurology
BackgroundRefractory chronic inflammatory demyelinating polyneuropathy (CIDP) is a challenging subset of CIDP. It does not respond well to immune therapy and causes substantial disability.
Yongsheng Zheng, Yongsheng Zheng, Yongsheng Zheng, Jianian Hu, Jianian Hu, Jianian Hu, Chong Sun, Chong Sun, Chong Sun, Kai Qiao, Yanyin Zhao, Yanyin Zhao, Yanyin Zhao, Bingyou Liu, Jian Sun, Jianying Xi, Jianying Xi, Jianying Xi, Sushan Luo, Sushan Luo, Sushan Luo, Jiahong Lu, Chongbo Zhao, Chongbo Zhao, Chongbo Zhao, Jie Lin, Jie Lin, Jie Lin   +27 more
doaj   +1 more source

Nipocalimab in Early‐Onset Severe Hemolytic Disease of the Fetus and Newborn

Pediatric Discovery, Volume 4, Issue 3, September 2026.
Aditya Hemedra Bhatt, Somashekhar Marutirao Nimbalkar, Dipen Vasudev Patel, Reshma Kushal Pujara   +3 more
wiley   +1 more source

Efficacy of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy with or without diabetes: insights from a multicenter prospective comparative study

Therapeutic Advances in Neurological Disorders
Background: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most frequently observed autoimmune neuropathy in patients with diabetes mellitus (DM). While intravenous immune globulin (IVIG) is a well-established treatment for CIDP,
Samir P. Macwan, Shalini Mahajan, Peter Novak, Khosro Farhad, Ericka Wong, Thomas H. Brannagan, Sohail Masood, Fawad Piracha, Marinos C. Dalakas   +8 more
doaj   +1 more source

Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP

BMC Neurology, 2017
Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is presented by a large heterogeneity of clinical phenotypes. Around 50% of patients suffer from typical CIDP and show better therapy response than atypical variants.
M. Staudt, J. M. Diederich, C. Meisel, A. Meisel, J. Klehmet   +4 more
doaj   +1 more source

Sonographic Characterization of Immune‐Mediated Peripheral Neuropathy

Clinical Neuroimaging
Background and Purpose Whether neuromuscular ultrasound (NMUS) can help differentiate between different types of immune‐mediated neuropathy remains unclear.
Mohamed Khateb, Monica Alcantara, Rodrigo Martinez‐Harms, Lubna Daniyal, Maria Andrea Morelos‐Andrade, Hamid Sadeghian, Vera Bril, Hans Katzberg   +7 more
doaj   +1 more source

AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)

Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2019
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous immune-mediated peripheral neuropathy with progressive or relapse-remitting course. Incidence of CIDP ranged between 1 and 8.9/100 000. Recently, most frequent therapies for CIDP
Roman A. Gapeshin, Evgeny R. Barantsevich, Dmitry I. Rudenko, Oksana V. Posokhina, Tima R. Stuchevskaya   +4 more
doaj   +1 more source

Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States

Frontiers in Neurology
BackgroundManagement of chronic inflammatory demyelinating polyneuropathy (CIDP) is challenged by heterogeneity in severity, comorbidities, potential adverse effects, and treatment accessibility.
Cécile Blein, Chafic Karam, Clémence Arvin-Berod, Deborah Gelinas, Sergio Barrera-Sierra, Hashmath Ulla T. A. Syed, Charlotte Ward, Amit Goyal, Jeffrey Guptill   +8 more
doaj   +1 more source

Exploring the Role of Nuclear Factor Kappa B in the Immunobiology of Inflammatory Neuropathies

Annals of Indian Academy of Neurology
Background and Objectives: Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are inflammatory conditions, representing prototype examples of immune-mediated disorders of the peripheral nervous system ...
Madhu Nagappa, Sandipan Mondal, B Pradeepkumar, Thrinath Mullapudi, Srinath Rajeevan, Pokala Akhil, Lakshminarayanapuram Gopal Viswanathan, Monojit Debnath   +7 more
doaj   +1 more source